Page 463 - Read Online

Maqboul et al. Mini-invasive Surg 2021;5:44 https://dx.doi.org/10.20517/2574-1225.2021.54 Page 11 of 19

Table 2. Robotic intracorporeal neobladder study series: the oncological outcomes

Number of patients had ≤pT2 Number of patients had Lymph node Mean follow up Patients with the Est. Disease Est. Overall
Study (organ confined) postoperative positive surgical yield (number) (months) for disease who are still survival rate DSR% Survival rate OSR%
in RIN margins in RIN cancer alive at follow up at 5 years at 5 years
[39]
Collins et al. 2014 n/a n/a n/a n/a n/a n/a n/a
[40]
Goh et al. 2012 6 0 55 n/a n/a n/a n/a
[5]
Hosseini et al. 2020 129 2 23 34 114 70 71
[20]
Obrecht et al. 11 n/a n/a n/a n/a n/a n/a
2020
[41]
Tyritzis et al. 2013 57 1 21 30 62 80.7 88.9
[42]
Desai et al. 2014 109 1 29 25 95 71 72
[13]
Tuderti et al. 2020 7 0 26 28 11 100 100
[43]
Schwentner et al. 38 4 23 37 52 76 71
2015
[44]
Gu et al. 2020 9 0 11 13 10 n/a n/a
[23]
Jonsson et al. 2011 35 1 19 25 31 84 n/a

RIN: Robotic intracorporeal neobladder.

Table 3. Robotic intracorporeal neobladder study series: the functional outcomes
Number of patients had daytime Number of patients had nighttime Number of patients achieved functionl erection Mean follow up for continence
Study
continence* continence (not aided) (months)
[39]
Collins et al. 2014 n/a n/a n/a 12
[40]
Goh et al. 2012 6 n/a n/a 3
[5]
Hosseini et al. 2020 n/a n/a n/a n/a
[20]
Obrecht et al. 12 9 n/a 6
2020
[41]
Tyritzis et al. 2013 48 40 12 12
[42]
Desai et al. 2014 62 n/a n/a 6
[13]
Tuderti et al. 2020 10 9 8 12
[43]
Schwentner et al. 54 34 27 37
2015
[44]
Gu et al. 2020 9 8 2 6
[23]
Jonsson et al. 2011 30 24 15 12

*Continence is defined as using 0-1 pads. Study excluded as follow up was less than 6 months. 73 patients only were followed for functional outcome.